Porównaj metody

	Dermatology Life Quality Index (DLQI)	Kwestionariusz Wpływu Fibromialgii
Dziedzina	Wyniki zdrowotne	Wyniki zdrowotne
Rodzina	Process / pipeline	Process / pipeline
Rok powstania	1994	1991
Twórca	Andrew Y. Finlay and Gul K. Khan	Cynthia S. Burckhardt et al.
Typ	Self-report quality of life questionnaire	Self-report symptom and functional impairment questionnaire
Źródło pierwotne	Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19(3), 210-216.	Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735.
Inne nazwy	DLQI, Finlay Index, Dermatology Quality of Life	FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire
Pokrewne	3	4
Podsumowanie	The DLQI is the primary patient-centered outcome measure in dermatology research and clinical practice. Developed by Andrew Finlay and Gul Khan in 1994, this 10-item self-report questionnaire quantifies the impact of skin disease on patients' daily functioning, emotional well-being, social relationships, and work capacity. It is simple, rapid, and applicable to virtually all dermatological conditions, making it the gold standard for assessing quality of life in dermatology.	The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice.